Headlines
-
Sprout grows its international markets
Wednesday | Jul 26 2023SPROUT Organic, an Australian vegan and organic infant formula company, has announced the launch of a new campaign in collaboration with the crowdfunding platform, Birchal.
-
777 stands against 60DD
Tuesday | Jul 25 2023PHARMACY 777 at Albion Park, NSW, is standing up against 60-day dispensing by supporting the Guild's Save Your Pharmacy campaign.
-
APC seeks input on draft
Tuesday | Jul 25 2023THE Australian Pharmacy Council (APC) has announced that stakeholders can now provide their feedback on the draft Performance Outcomes for the education programs that will credential pharmacists to work in aged care and conduct medication management reviews.
-
Teva Pharma joins GBMA
Tuesday | Jul 25 2023ISRAELI-FOUNDED Teva Pharma Australia joined the Generic and Biosimilar Medicines Association (GBMA) recently.
-
Sale to Jonas by Corum
Monday | Jul 24 2023CORUM Group Ltd has agreed to sell its Pharmacy Software business to Jonas Software AUS Pty LTD for a total cash deal of $6.25m subject to customary completion adjustments (PD Breaking News Fri).
-
New Pharmacy Daily era
Monday | Jul 24 2023PHARMACY Daily's parent firm, the Business Publishing Group, has a new General Manager, with Davy Adams (pictured) today taking on the position under new private equity owners.
-
SHPA’s growth strategy
Monday | Jul 24 2023EMBARKING on a growth agenda for the next 12 months, the Society of Hospital Pharmacists of Australia (SHPA) has released today its Transformation 2024 strategy, HERE.
-
APA’s most outstanding
Friday | Jul 21 2023PHARMACIST Jason Sammut (pictured), has taken out the Australian Patients Association (APA) Most Outstanding Community Pharmacist Award 2023.
-
Michaels is reappointed
Friday | Jul 21 2023KRISTIN Michaels (pictured) has been reappointed to lead the Society of Hospital Pharmacists of Australia (SHPA), the organisation has announced as it prepares to unveil its Transformation 2024 agenda.
-
Key site for biosimilars
Friday | Jul 21 2023GENERIC and biosimilar medicines manufacturer Sandoz has announced an investment of approximately US$90m (A$131.8m) at its site in Ljubljana, Slovenia to establish a dedicated Sandoz Biopharma Development Center by 2026.